pigmentary retinopathy and a lack of cardiomyopathy, are commonly observed. Early small, open-label trials of vitamin E in FRDA did not show any therapeutic effect. More recently, but again in an ...
Kovach mentioned pigmentary maculopathy with the use of pentosan polysulfate sodium and said that Ozempic (semaglutide, Novo Nordisk) may “accelerate the progression of diabetic retinopathy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback